GLS expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.062600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.187200E-01
Normal-vs-Stage2
4.502300E-02
Normal-vs-Stage3
1.489740E-02
Normal-vs-Stage4
2.846600E-01
Stage1-vs-Stage2
4.407000E-01
Stage1-vs-Stage3
1.669160E-01
Stage1-vs-Stage4
6.027000E-01
Stage2-vs-Stage3
1.215450E-01
Stage2-vs-Stage4
8.319000E-01
Stage3-vs-Stage4
2.593200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.402200E-01
Normal-vs-AfricanAmerican
4.210000E-01
Normal-vs-Asian
1.145550E-02
Caucasian-vs-AfricanAmerican
7.826000E-01
Caucasian-vs-Asian
2.518100E-02
AfricanAmerican-vs-Asian
7.013700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.957800E-01
Normal-vs-Female
6.695600E-02
Male-vs-Female
1.609400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.881400E-01
Normal-vs-Age(41-60Yrs)
7.845400E-01
Normal-vs-Age(61-80Yrs)
1.543770E-01
Normal-vs-Age(81-100Yrs)
8.573900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.460200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.674400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.640000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.172400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.160100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.216000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.393900E-02
Normal-vs-Daily Drinker
8.923500E-03
Normal-vs-Weekly Drinker
4.304200E-02
Normal-vs-Occasional Drinker
9.878400E-01
Normal-vs-Social Drinker
2.244600E-01
Non Drinker-vs-Daily Drinker
4.159400E-01
Non Drinker-vs-Weekly Drinker
8.628400E-01
Non Drinker-vs-Occasional Drinker
2.407600E-01
Non Drinker-vs-Social Drinker
3.680800E-01
Daily Drinker-vs-Weekly Drinker
5.945400E-01
Daily Drinker-vs-Occasional Drinker
1.753790E-01
Daily Drinker-vs-Social Drinker
1.268250E-01
Weekly Drinker-vs-Occasional Drinker
2.275600E-01
Weekly Drinker-vs-Social Drinker
3.749200E-01
Occasional Drinker-vs-Social Drinker
3.796400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.209000E-01
Normal-vs-Grade 2
2.480200E-02
Normal-vs-Grade 3
2.625700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.393000E-01
Grade 1-vs-Grade 3
2.965000E-01
Grade 1-vs-Grade 4
4.209000E-01
Grade 2-vs-Grade 3
5.704600E-01
Grade 2-vs-Grade 4
2.480200E-02
Grade 3-vs-Grade 4
2.625700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.892400E-01
Normal-vs-NonDiabetic
2.318200E-01
Diabetic-vs-NonDiabetic
5.800000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.755130E-03
Normal-vs-NoPancreatitis
4.827600E-01
Pancreatitis-vs-NoPancreatitis
3.323300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.547200E-01
Normal-vs-N1
5.105700E-02
N0-vs-N1
9.341000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.491700E-02
Normal-vs-TP53-NonMutant
7.093600E-01
TP53-Mutant-vs-TP53-NonMutant
1.504970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
GLS expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.062600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.187200E-01
Normal-vs-Stage2
4.502300E-02
Normal-vs-Stage3
1.489740E-02
Normal-vs-Stage4
2.846600E-01
Stage1-vs-Stage2
4.407000E-01
Stage1-vs-Stage3
1.669160E-01
Stage1-vs-Stage4
6.027000E-01
Stage2-vs-Stage3
1.215450E-01
Stage2-vs-Stage4
8.319000E-01
Stage3-vs-Stage4
2.593200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.402200E-01
Normal-vs-AfricanAmerican
4.210000E-01
Normal-vs-Asian
1.145550E-02
Caucasian-vs-AfricanAmerican
7.826000E-01
Caucasian-vs-Asian
2.518100E-02
AfricanAmerican-vs-Asian
7.013700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.957800E-01
Normal-vs-Female
6.695600E-02
Male-vs-Female
1.609400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.881400E-01
Normal-vs-Age(41-60Yrs)
7.845400E-01
Normal-vs-Age(61-80Yrs)
1.543770E-01
Normal-vs-Age(81-100Yrs)
8.573900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.460200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.674400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.640000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.172400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.160100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.216000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.393900E-02
Normal-vs-Daily Drinker
8.923500E-03
Normal-vs-Weekly Drinker
4.304200E-02
Normal-vs-Occasional Drinker
9.878400E-01
Normal-vs-Social Drinker
2.244600E-01
Non Drinker-vs-Daily Drinker
4.159400E-01
Non Drinker-vs-Weekly Drinker
8.628400E-01
Non Drinker-vs-Occasional Drinker
2.407600E-01
Non Drinker-vs-Social Drinker
3.680800E-01
Daily Drinker-vs-Weekly Drinker
5.945400E-01
Daily Drinker-vs-Occasional Drinker
1.753790E-01
Daily Drinker-vs-Social Drinker
1.268250E-01
Weekly Drinker-vs-Occasional Drinker
2.275600E-01
Weekly Drinker-vs-Social Drinker
3.749200E-01
Occasional Drinker-vs-Social Drinker
3.796400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.209000E-01
Normal-vs-Grade 2
2.480200E-02
Normal-vs-Grade 3
2.625700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.393000E-01
Grade 1-vs-Grade 3
2.965000E-01
Grade 1-vs-Grade 4
4.209000E-01
Grade 2-vs-Grade 3
5.704600E-01
Grade 2-vs-Grade 4
2.480200E-02
Grade 3-vs-Grade 4
2.625700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.892400E-01
Normal-vs-NonDiabetic
2.318200E-01
Diabetic-vs-NonDiabetic
5.800000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.755130E-03
Normal-vs-NoPancreatitis
4.827600E-01
Pancreatitis-vs-NoPancreatitis
3.323300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.547200E-01
Normal-vs-N1
5.105700E-02
N0-vs-N1
9.341000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.491700E-02
Normal-vs-TP53-NonMutant
7.093600E-01
TP53-Mutant-vs-TP53-NonMutant
1.504970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
